Quantcast
Russia to begin Phase III trials of second COVID-19 vaccine in Nov-Dec: TASS - Metro US

Russia to begin Phase III trials of second COVID-19 vaccine in Nov-Dec: TASS

FILE PHOTO: A woman holds a small bottle labeled with a "Vaccine COVID-19" sticker and a medical syringe in this illustration

MOSCOW (Reuters) – Russia will begin Phase III trials of a second potential vaccine against COVID-19, developed by Siberia’s Vector Institute, in November-December, the TASS news agency cited Russian consumer safety watchdog Rospotrebnadzor as saying on Friday.

Early-stage clinical trials for the vaccine were completed on Wednesday.

(Writing by Alexander Marrow; Editing by Polina Ivanova)

More from our Sister Sites